Oragenics Inc (OGEN)
0.30
-0.02
(-6.10%)
USD |
NYAM |
Oct 31, 16:00
0.30
0.00 (0.00%)
After-Hours: 20:00
Oragenics Cash from Operations (Quarterly): -1.544M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -1.544M |
March 31, 2024 | -3.064M |
December 31, 2023 | -1.102M |
September 30, 2023 | -1.503M |
June 30, 2023 | -2.577M |
March 31, 2023 | -2.109M |
December 31, 2022 | -2.433M |
September 30, 2022 | -3.776M |
June 30, 2022 | -3.383M |
March 31, 2022 | -5.637M |
December 31, 2021 | -2.485M |
September 30, 2021 | -4.580M |
June 30, 2021 | -2.078M |
March 31, 2021 | -4.327M |
December 31, 2020 | -3.632M |
September 30, 2020 | -4.666M |
June 30, 2020 | -4.833M |
March 31, 2020 | -3.823M |
December 31, 2019 | -3.936M |
September 30, 2019 | -3.378M |
June 30, 2019 | -3.488M |
March 31, 2019 | -2.211M |
December 31, 2018 | -2.978M |
September 30, 2018 | -2.454M |
June 30, 2018 | -2.281M |
Date | Value |
---|---|
March 31, 2018 | -1.367M |
December 31, 2017 | -1.359M |
September 30, 2017 | -1.340M |
June 30, 2017 | -1.765M |
March 31, 2017 | -1.900M |
December 31, 2016 | -1.964M |
September 30, 2016 | -1.571M |
June 30, 2016 | -1.92M |
March 31, 2016 | -1.620M |
December 31, 2015 | -1.662M |
September 30, 2015 | -1.296M |
June 30, 2015 | -0.9437M |
March 31, 2015 | -1.288M |
December 31, 2014 | -1.181M |
September 30, 2014 | -1.098M |
June 30, 2014 | -1.696M |
March 31, 2014 | -1.584M |
December 31, 2013 | -1.219M |
September 30, 2013 | -1.964M |
June 30, 2013 | -2.000M |
March 31, 2013 | -1.581M |
December 31, 2012 | -1.741M |
September 30, 2012 | -1.178M |
June 30, 2012 | -1.150M |
March 31, 2012 | -1.143M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.637M
Minimum
Mar 2022
-1.102M
Maximum
Dec 2023
-3.236M
Average
-3.383M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
Shuttle Pharmaceuticals Holdings Inc | -1.399M |
Perspective Therapeutics Inc | -8.902M |
Alaunos Therapeutics Inc | -1.681M |
Cocrystal Pharma Inc | -3.699M |
Cara Therapeutics Inc | -12.44M |
Cash from Operations (Quarterly) Related Metrics
Cash from Financing (Quarterly) | 0.8212M |
Free Cash Flow | -7.214M |
Free Cash Flow Per Share (Quarterly) | -0.341 |
Free Cash Flow Yield | -741.6% |